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Abstract
The regulation of proviral latency is a central problem in retrovirology. We postulate that the genomic integration site of
human T lymphotropic virus type 1 (HTLV-1) determines the pattern of expression of the provirus, which in turn determines
the abundance and pathogenic potential of infected T cell clones in vivo. We recently developed a high-throughput method
for the genome-wide amplification, identification and quantification of proviral integration sites. Here, we used this protocol
to test two hypotheses. First, that binding sites for transcription factors and chromatin remodelling factors in the genome
flanking the proviral integration site of HTLV-1 are associated with integration targeting, spontaneous proviral expression,
and in vivo clonal abundance. Second, that the transcriptional orientation of the HTLV-1 provirus relative to that of the
nearest host gene determines spontaneous proviral expression and in vivo clonal abundance. Integration targeting was
strongly associated with the presence of a binding site for specific host transcription factors, especially STAT1 and p53. The
presence of the chromatin remodelling factors BRG1 and INI1 and certain host transcription factors either upstream or
downstream of the provirus was associated respectively with silencing or spontaneous expression of the provirus. Cells
expressing HTLV-1 Tax protein were significantly more frequent in clones of low abundance in vivo. We conclude that
transcriptional interference and chromatin remodelling are critical determinants of proviral latency in natural HTLV-1
infection.
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Introduction
It is poorly understood how the flanking host genome influences
transcription of an integrated provirus. Experiments on artificially
modified proviral reporter constructs have yielded contradictory
evidence on the role of flanking host promoters in either driving
proviral transcription, or suppressing it by transcriptional inter-
ference [1,2]. Conclusions from experiments on single artificial
clones therefore cannot be reliably generalized: evidence is
required from genome-wide studies of integrated proviruses in
natural infection.
Human T lymphotropic virus Type 1 (HTLV-1) persists in vivo by
two routes: by driving selective clonal proliferation of infected T
lymphocytes (‘mitotic spread’) and by de novo infection (‘infectious
spread’) via the virological synapse [3]. HTLV-1 replication is
counterbalanced by a strong, chronically activated cytotoxic T
lymphocyte (CTL) immune response [4]. The HTLV-1 proviral load
(number of proviral copies per 100 PBMCs) varies between infected
individuals by over 1000-fold. The proviral load is the strongest
correlate of HTLV-1 associated diseases, in particular Adult T-cell
Leukemia-Lymphoma (ATLL, [5]) and HTLV-1 Associated Mye-
lopathy/Tropical Spastic Paraparesis (HAM/TSP, [6]).
Mitotic spread of HTLV-1 results in expanded clones of cells
that carry the provirus in the same genomic integration site [7].
Infectious spread results in integration of the provirus at a new
genomic position. We have recently shown that the majority of
naturally infected T-cell clones carry a single proviral copy [8].
Integration of HTLV-1 does not favour specific hotspots, but is
more frequent in transcriptionally active areas of the genome
[9,10,11]. However, the factors that determine integration
targeting and the abundance and expression of the HTLV-1
provirus in vivo are unknown. Two HTLV-1 gene products are
thought to play a crucial role in viral persistence in vivo. Tax, the
transcriptional transactivator of the virus, elicits abundant,
chronically activated CTLs [12,13,14], indicating continuous or
repeated expression of Tax in vivo. Ex vivo, Tax protein is
spontaneously expressed in a fraction of infected peripheral blood
mononuclear cells (PBMCs) after overnight culture [15]. HBZ is
the only gene expressed from the minus strand of the provirus.
HBZ also promotes infected cell proliferation [16] and the CTL
response to HBZ protein is a key determinant of proviral load and
the risk of the inflammatory disease HAM/TSP [17,18]. Tax
enhances HBZ expression; HBZ protein exerts negative feedback
on Tax expression [19,20].
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We hypothesize that the genomic integration site of HTLV-1
determines the pattern and intensity of expression of the plus and
minus proviral strands, which in turn determine the equilibrium
abundance and the pathogenic potential of an infected T cell clone
in vivo. To test this hypothesis, we used our recently described
protocol [11] of high-throughput mapping and quantification of
proviral integration sites in fresh primary PBMCs from HTLV-1-
infected individuals.
Results
HTLV-1 preferentially integrates within 1 kb of a host
transcription start site and is strongly biased to specific
transcription factor binding sites
To identify genomic factors associated with the targeting of
HTLV-1 integration, we infected Jurkat T cells by short co-culture
with the HTLV-1-producing cell line MT2. The integration sites
were then analysed using our high-throughput protocol and
compared to a control list of random sites in the human genome.
Figure 1A illustrates the possible orientations (same or opposite) of
the nearby genomic features, such as transcription start sites, either
upstream or downstream of the integrated provirus.
We previously showed [11] that 47% of de novo HTLV-1
proviral integration events lie within a RefSeq gene. This
frequency is slightly higher than expected by chance, but is much
lower than that observed for HIV (,70%), which uses the host
protein LEDGF to target proviral integration to genes [21]. As
expected by chance, ,50% of proviruses integrated within host
genes were in the same transcriptional orientation as the host gene
(Figure 1D, in vitro).
Gillet et al [11] reported a significantly higher than expected
proportion of in vitro integration sites within 10 kb of a RefSeq
gene. We extended this analysis to identify the optimal (most
frequent) distance between the integration site and the nearest host
transcription start site (TSS). The results (Figure 1B) show a peak
preference (measured by the odds ratio, OR, observed/expected)
towards integration in proximity to TSS at,1 kb of the integrated
provirus (upstream or downstream); the OR gradually diminished
until it reached 1 (same as random expectation) at ,1 Mb from
the integration site (Figure 1B). There was a small bias (non-
significant for in vitro integration) towards integration with a TSS
downstream of the integration site (Figure 1C, in vitro).
Similarly, we observed a bias (up to 2-fold greater than random)
towards integration in proximity to CpG islands; again, the bias
reached a peak at 1 kb from the nearest CpG island (supplemen-
tary Figure S4).
We showed previously [11] that HTLV-1 provirus preferentially
integrates in transcriptionally active regions of the host genome.
To test the hypothesis that specific transcription factor binding
sites (TFBS) influence HTLV-1 proviral targeting, expression and
clonal abundance, we used data on genome-wide TFBS ChIP-seq:
where available, from primary CD4+ T cells; otherwise, from T
cells or other human cell types; see Table S3 for complete listing of
the datasets used.
In vitro integration sites showed a remarkably strong bias
(compared with random sites) towards integration in proximity to
specific TFBS, in particular STAT1, p53, HDACs (e.g. HDAC3,
HDAC6) and HATs (e.g. p300, CBP) (Table S3). In most cases the
effect was localized to within 100–1000 bases of the integration site
(Figure 2A) and declined sharply at greater distances. Two
patterns were observed in this biased integration. First, the
preference towards integration in proximity to TFBS was typically
symmetrical (e.g. p300), i.e. equally strong upstream and
downstream of the integration site but in some cases was
asymmetrical (e.g. STAT1), with a bias towards one side (often
downstream). Second, in many cases we observed a sharp decrease
in the preferential integration at 10 bases from the TFBS, such as
STAT1 Figure 2A). This pattern was consistently observed across
several in vitro and in vivo datasets (supplementary Figures S1,
S2).
Because certain TFBS are frequently co-located in the human
genome [22], we wished to test which TFBS were independently
associated with targeting of the integration site. First, a likelihood
ratio test was used to test whether the TFBS was selectively
associated with integration either upstream or downstream of the
integration site, and each TFBS was then tested individually using
a univariate model. We then combined all significant factors using
a step-down multivariate logistic regression analysis until only
independently significant (p,0.05) factors remained. Most factors
that were independently associated with integration site targeting
occurred with equal frequency upstream or downstream of the
integration site (Figure 2B, see also supplementary Table S7). The
factors with the highest odds ratios were the transcription factor
p53 and the histone deacetylase HDAC6.
Effect of HTLV-1 integration sites on clonal expansion
We previously reported [11] a significant association between
certain features in the flanking genome and in vivo expansion of
the infected T-cell clone. Here, we found that proviruses
integrated within a gene were more frequent in larger (more
abundant) clones than in smaller clones in vivo, but only when the
provirus was integrated in the same transcriptional orientation as
the host gene (Figure 1D); the frequency of integration in the
opposite orientation was not positively correlated with clonal
abundance.
High clone abundance (Figure 1C, top two bins) was associated
with the presence of a host TSS within 1 kb downstream of the
provirus; here, the transcriptional orientation of the provirus had
less effect on abundance than in the case of proviruses integrated
within a host gene. The excess frequency of TSS downstream (but
not upstream) was much higher in integration sites in vivo than in
vitro, in particular when the provirus was integrated in the same
orientation as the nearby host gene (p(same) ,1025; p(opposite)
,0.05, x2 test). The presence of a host CpG island within 1 kb
downstream was also selectively associated with clone high
abundance (Figure 1E).
Author Summary
HTLV-1 is a human retrovirus, estimated to infect over 10
million individuals worldwide, which causes the inflamma-
tory disease HTLV-1-associated Myelopathy/Tropical Spas-
tic Paraparesis and an aggressive malignancy known as
Adult T-cell Leukemia/Lymphoma. The mechanisms that
allow the virus to maintain a life-long infection are not fully
understood. Here we identified attributes of the host
genome flanking the integrated HTLV-1 provirus associat-
ed with integration targeting and spontaneous expression
of the provirus in vitro, and clonal expansion in vivo.
Spontaneous expression (after short-term culture) of the
viral protein Tax, which is known to drive proliferation of
the infected cell, was significantly more frequent among
less expanded clones, suggesting that Tax-expressing
clones are more efficiently controlled by the immune
response. Certain transcription start sites immediately
upstream of the viral integration site were associated with
virus latency, which in turn was associated with clonal
expansion in vivo.
Proviral Integration, Abundance and Expression
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Figure 1. Genomic environment at HTLV-1 proviral integration site determines integration in vitro and abundance in vivo. (A) Blue
blocks denote a genomic feature such as a transcription start site. The distance to the nearest genomic feature is calculated (unless otherwise stated)
separately for features upstream (closer to 59 LTR) and downstream of the provirus. Unless otherwise stated, distance is calculated to the nearest end
of the genomic feature. Where the genomic feature has an orientation (i.e. transcription units) its orientation relative to the transcriptional orientation
of the provirus is indicated as ‘‘same’’ or ‘‘opposite’’. (B) to (E): proportion of observed integration sites compared to random expectation. (B)
Frequency of integration in proximity to transcriptional units (RefSeq). In vitro denotes a combined dataset from two independent experiments (see
Table 1). (C) Frequency of integration within 1 kb of a TSS according to clonal abundance (cells in a given clone per 10 000 PBMCs). (D) The excess
frequency (compared with random) of observing a provirus within a transcription unit was greater among abundant clones in vivo integrated in the
same transcriptional orientation (blue) but not in opposite orientation (orange). (E) The excess frequency (compared with random) of observing a
provirus within 1 kb of a host CpG island increased with increasing clonal abundance, in particular where the CpG island lay downstream of the
integration site.
doi:10.1371/journal.ppat.1003271.g001
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Figure 2. Influence of host TFBS on integration site targeting. (A) Bias in integration in proximity to TFBS (based on ChIP-seq experiments),
measured by the odds ratio compared to random expectation. Four representative plots are shown; see also supplementary information. The excess
frequency of integration in proximity to TFBS was frequently greater in in vitro infection than in clones isolated from PBMCs in vivo, and greater in
low abundance clones in vivo than high abundance clones in vivo (see bottom right panel and supplementary information). Arrows indicate a
Proviral Integration, Abundance and Expression
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Integration sites observed in vivo showed a similar bias towards
proximity to TFBS, with two important differences. First, the OR
was in each case lower than that observed in in vitro integration.
Second, the magnitude of the bias (OR) declined as clonal
abundance increased (Figure 3; supplementary Figure S3).
Effect of HTLV-1 integration site on Tax expression
We wished to identify features of the genomic integration site
that favour expression of the HTLV-1 provirus. We hypothesized
that the genomic environment flanking the proviral integration site
determines the rate of spontaneous expression of the HTLV-1
transactivator protein Tax by a given infected T-cell clone: that is,
the proportion of cells in that clone that express Tax within a given
time interval. CD8+ T-cells were depleted from fresh unstimulated
PBMCs of 10 infected HAM/TSP patients (to preclude CTL-
mediated lysis), and the CD82 population was incubated in vitro
overnight to allow spontaneous expression of the Tax protein [15].
We then sorted the cells by flow cytometry to isolate Tax+ and
Tax2 cells and analysed the integration sites in the two cell
fractions.
We measured the proportion of each clone that spontaneously
expressed Tax by quantifying individual integration sites in the
Tax+ and Tax2 cells, (Figure 4E, and supplementary Figure S7).
The observed proportion of Tax+ cells per clone varied between
0% and 100%. The majority of clones, regardless of clonal
abundance, were either .90% Tax+ or .90% Tax2. This
observation is consistent with the hypothesis that the rate of
spontaneous expression of Tax is an intrinsic property of each
clone and is determined by the proviral integration site.
When the provirus was integrated within a host gene, we
observed a slight but significant excess frequency of Tax+ cells
compared with Tax2 cells (46% vs 43% respectively, p,1023, x2
test). However, while the proviruses in the Tax+ cells were found
with equal frequency in the same or the opposite transcriptional
orientation to the host gene in which they were integrated, the
Tax2 cells were significantly more frequently present in the same
orientation as the host gene (52% of Tax+ vs 59% of Tax2 cells,
p,10215, x2 test). Thus, T cell clones that were 100% Tax2 were
significantly more likely to carry a provirus in the same orientation
as the host gene (Figure 4B).
The relative position (upstream or downstream of the integra-
tion site) and the transcriptional orientation of the nearest host
gene influenced not only the clonal abundance (Figure 1) but also
spontaneous Tax expression. Where the nearest host gene lay in
the same transcriptional orientation as the HTLV-1 provirus, the
presence of a host TSS (Figure 4A) or CpG island (Figure 4C)
within 1 kb upstream of the provirus was associated with silencing
of Tax, whereas a TSS or CpG island within 1 kb downstream
was associated with Tax expression. The closer the upstream gene
was to the integration site, the lower was the proportion of Tax+
cells if the gene was in the same orientation (Figure 4D). In
contrast, where the nearest host gene was in opposite transcrip-
tional orientation, this asymmetrical effect of the nearby host gene
was not observed (Figure 4A, right-hand panel; Figure 4D).
The mean proportion of Tax+ cells in one clone (across all clone
abundance classes) was 60%. We wished to test whether proximity
to TFBS would alter this proportion. We found that the presence
of certain TFBS (including STAT1, cJun, NRSF) within 1 kb
upstream of the integration site was associated with a higher
proportion of Tax+ cells in the respective T-cell clone (Figure 5A).
A notable exception was BRG-1, which showed a strong opposite
asymmetric effect: cells containing a BRG-1 site just upstream of
the provirus were more likely to be Tax2, whereas cells with a
BRG-1 site just downstream of the provirus were more likely to be
Tax+ (Figure 5A, top left panel).
To identify the TFBS that were independently and significantly
associated with spontaneous Tax expression, a logistic regression
analysis was carried out as described above (Figure 2B) for
integration site targeting. The results (Figure 5B, see also
supplementary Table S7) confirmed the asymmetric effects of
the BRG-1 binding site, and in addition revealed significant
symmetrical (p300) or asymmetrical (STAT1) bias towards integration in proximity to TFBS, as well as a lower bias in close proximity to IS (STAT1). See
also supplementary Table S4 for underlying data. (B) TFBS independently associated with integration frequency in vitro were identified by
multivariate analysis. OR – odds ratio. TFBS shown above the line were associated with an excess frequency of integration compared with random
(OR.1); TFBS below the line were significantly less likely to lie near the provirus (OR,1). Model 1 and Model 2 (carried out independently) test for
TFBS within 1 kb and 100 bp of IS, respectively.
doi:10.1371/journal.ppat.1003271.g002
Figure 3. Influence of host TFBS on clonal abundance. Bias in
integration in proximity to TFBS (based on ChIP-seq experiments),
measured by the odds ratio compared to random expectation. Two
representative plots are shown; see also supplementary Figure S3. The
excess frequency of integration in proximity to TFBS was greater in low
abundance clones in vivo than high abundance clones in vivo. See also
supplementary Table S5 for underlying data.
doi:10.1371/journal.ppat.1003271.g003
Proviral Integration, Abundance and Expression
PLOS Pathogens | www.plospathogens.org 5 March 2013 | Volume 9 | Issue 3 | e1003271
asymmetric associations between Tax expression and several other
TFBS, notably STAT1, NRSF, and HDAC1. Thus, a STAT1
binding site 100 bp upstream of the provirus strongly favoured Tax
expression, but the presence of a downstream STAT1 binding site
was not an independent predictor of Tax expression after
multivariate analysis. Conversely, an NRSF binding site 100 bp
downstream was a significant predictor of Tax negativity, but the
closest upstream NRSF binding site was not independently
associated with Tax expression. The asymmetry of these associa-
tions contrasts with the predominantly symmetrical associations
observed between TFBS and integration site targeting (Figure 2B),
and suggests a mechanistic interaction between transcription of the
provirus and transcription of the flanking host genome.
Tax+ cells are more frequent in low-abundance clones
To test the hypothesis that the level of Tax expression is
correlated with the in vivo abundance of the infected T cell clone,
we divided all detected clones into four abundance bins based on
the total number of cells observed in each clone. There was a
significant negative correlation between clone abundance and the
proportion of Tax+ cells in the respective abundance bin (Figure 5).
That is, small clones were more likely to be Tax+, and this
likelihood decreased as clone abundance increased. We conclude
that, at least in cells from HAM/TSP patients, the majority of
spontaneous Tax expression observed is due to the large number
of low-abundance clones, rather than a small number of high-
abundance clones.
Figure 4. Genomic environment at HTLV-1 proviral integration site associated with proviral expression after 18 h in culture. CD8-
depleted PBMCs were placed in culture overnight and sorted by flow cytometry to isolate Tax+ and Tax2 cells, followed by integration site analysis of
sorted cells. (A)–(C): proportion of observed integration sites compared to random expectation. (A) Frequency of integration in proximity to
transcriptional units (RefSeq) in clones that were 100% Tax+ or 100% Tax2, according to the relative transcriptional orientation of the provirus and the
host gene. The peak of integration at 1 kb mirrors that observed in vivo in unsorted cells (Figure 1B). However, the integration site in Tax2 clones was
more likely than in Tax+ clones to possess a nearby upstream TSS in the same orientation, and less likely to lie nearby a downstream TSS in the same
orientation (or any relative position in the opposite orientation). (B) The provirus in Tax2 clones (blue) was oriented in the same transcriptional sense
as the host gene in which it was integrated more frequently than random. The orientation of Tax+ clones (pink) did not differ from random. (C)
Frequency of integration in proximity to CpG islands in clones that were 100% Tax+ or 100% Tax2. The peak of integration at 1 kb mirrors that
observed in vivo in unsorted cells and in vitro (Figure S4). (D) Mean fraction of Tax+ cells in clones with a TSS at a given distance (log scale) from the
integration site, according to the relative transcriptional orientation of the provirus and the host TSS. The dotted line denotes the mean fraction of
Tax+ cells across all clones. (E) Frequency distribution of clones according to the frequency of Tax+ cells in the respective clones. See supplementary
Figure S7 for detailed frequency distribution separated according to clone abundance.
doi:10.1371/journal.ppat.1003271.g004
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Figure 5. Influence of proximity to TFBS on Tax expression. (A) Mean fraction of Tax+ cells in clones with a TFBS (based on ChIP-seq
experiments) at a given distance from the IS. Four representative plots are shown. (B) TFBS that were independently associated with Tax expression
were identified by multivariate analysis, outcome measure . TFBS shown above the line were associated with Tax expression (OR.1); TFBS below the
line were associated with Tax silencing (OR,1). Model 1 and Model 2 (carried out independently) test for TFBS within 1 kb and 100 bp of IS,
respectively.
doi:10.1371/journal.ppat.1003271.g005
Proviral Integration, Abundance and Expression
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Discussion
An understanding of the regulation of proviral latency is
required for attempts to eradicate latent retroviruses and to
optimize retroviral vectors for in vitro and in vivo use. In HIV-1
infection, a reservoir of latently infected cells persists indefinitely in
the face of antiretroviral drug therapy and precludes eradication of
the infection (reviewed in [23]). In HTLV-1 infection, proviral
expression is difficult to detect in fresh PBMCs: however, the
strong, chronically activated host immune response and the
selective oligoclonal proliferation of HTLV-1-infected T cells
argue that the virus is continuously or intermittently expressed in
vivo [4,24].
The abundance of an HTLV-1-infected T cell clone in vivo will
be determined by the net effect of two main selection forces: its
ability to proliferate and its susceptibility to killing by the strong
CTL response [4]. If these forces acted upon all clones equally, the
clones would have the same relative abundance in the host.
However, Gillet et al [11] showed a wide variation in clone
abundance both within and between infected individuals and over
time. We hypothesized that this variation between clones is caused
by the genomic environment of the integrated provirus, by
determining the frequency and intensity of expression of proviral
genes, in particular Tax and HBZ, which in turn promote cell
proliferation and thereby confer a selective advantage on the
infected T cell clone.
To identify the host genomic factors that determine integration
site targeting, we mapped and quantified proviral integration sites
isolated from two independent in vitro infection experiments. We
assume that the pattern of integration observed in short-term in
vitro infection reflects the initial pattern of integration in vivo,
before the selection exerted during chronic infection. The results
confirmed our previous observations [10,11] that the virus is
targeted to transcriptionally active regions of the genome, within
or near to a host gene. There was no bias in the orientation of the
provirus in the initial infection, indicating that the bias observed in
integration sites isolated from PBMCs is a result of the long-term
selection forces acting on the infected clones in vivo.
We observed a bias towards integration in proximity to
particular transcription factor binding sites. This bias was
remarkably strong in certain cases (STAT1, NRSF) in single-
factor analysis. Because clusters of different TFBS are frequent in
the genome [22], we carried out a multivariate (logistic regression)
analysis to identify the TFBS that were independently and
significantly associated with an excess frequency of integration.
The results (Figure 2B) confirmed the identification of p53,
HDAC6 and STAT1 as significant independent correlates of
integration. Further independent predictors of integration includ-
ed Ini1 (see below), cMyc, cJun and NF-kB (Figure 2B). p53 and
STAT1 both play important roles in HTLV-1 infection. HTLV-1
dysregulates p53 signalling pathways in vivo [25]; it is not known
whether insertional mutagenesis contributes to this dysregulation.
HTLV-1 also causes widespread activation of interferon-stimulat-
ed genes in vivo, including the key transcriptional regulator
STAT1 [25]. A strong association was reported between STAT1
and MLV integration [26]; the authors attributed this to an
association between MLV integration and particular epigenetic
marks (H3K4me3, H3K4me1 and H3K9ac) at the integration site.
The proportion of all integration sites near any one TFBS was
in the minority. This observation indicates that proximity to the
transcription factor binding site itself is not sufficient for
integration, but suggests that these transcription factors (or an
associated host factor) increase the efficiency of proviral integra-
tion. Host factors associated with HIV integrase have been
thoroughly studied [27]; the most important is the lens epithelium-
derived growth factor (LEDGF/p75, [28]), which determines
integrase localization [29] and targeting of HIV integrase to
transcription units [21]. A study of host factors associated with
HTLV-1 integrase is currently underway.
The observed bias towards integration near certain TFBS was
predominantly symmetrical and short-range, reaching a maximum
at 100b from the integration site and falling to random expectation
at,10 kb (Figure 2A). In many instances the bias dropped sharply
at less than 100b from the integration site: we suggest that this
drop is due to steric hindrance between the pre-integration
complex and the DNA-bound transcription factor.
In contrast to the symmetry observed in the association between
genomic features (such as TFBS) and the frequency of initial
integration, we found significant asymmetric interactions between
the flanking host genome and the integrated provirus in
determining clonal abundance and spontaneous proviral expres-
sion. Both the relative position of the nearest host gene (upstream
or downstream of the provirus) and its relative transcriptional
orientation showed significant associations with clone abundance
and expression. Previous studies [1,2] reported contradictory
evidence on the role of an upstream same-sense host promoter in
either promoting or suppressing proviral transcription. More
recently, Shan et al [30] have shown in Bcl-2-transduced CD4+ T
cells, infected in vitro with GFP expressing modified HIV, that
persistent expression of GFP was associated with opposite sense
orientation, while inducible expression was associated with same
sense orientation. The evidence obtained here demonstrates that,
in natural HTLV-1 infection, the presence of a same-sense host
gene promoter upstream of the integrated provirus is associated
with inhibition of spontaneous proviral expression, suggesting the
operation of transcriptional interference. We conclude that the
transcriptional interaction between host and HTLV-1 operates at
two levels. First, at a regional level – within 10 kb of the provirus –
transcriptional activity of the flanking host genome favours
proviral gene expression [10,11], presumably because of accessi-
bility of the euchromatin to transcription complexes. Second, at a
local level – within 100b to 1000b – transcriptional interference by
a same-sense host promoter within 1 kb upstream can override the
regional effect and inhibit proviral transcription.
Two observations reported here demonstrate that proviral
integration and expression are not determined simply by the
accessibility of chromatin. First, whereas some TFBS were
associated with HTLV-1 proviral integration more frequently
than expected, the frequency of other TFBS showed no such bias.
Second, the asymmetric associations observed between proviral
orientation and position with respect to flanking host genes and the
abundance and expression of the HTLV-1 provirus argue for a
mechanistic interaction between transcription of the HTLV-1
provirus and transcription of the flanking host genome.
An observation of particular interest is the opposing effect of a
BRG-1 binding site upstream and downstream of the provirus
(Figure 5A). BRG-1, one of the two ATPase components required
for the activity of the SWI/SNF complex [31], controls gene
expression by remodelling chromatin, i.e. by repositioning
nucleosomes to control the access of transcriptional complexes to
the DNA. BRG-1 can cause both gene repression [32] and gene
activation [33]; the balance appears to depend on which other
subunits are recruited to the SWI/SNF complex [34]. Easley et al
[35] found that BRG-1 is required for Tax expression and HTLV-
1 replication in vitro, and Rafati et al [36] found that the BAF
subclass of the SWI/SNF complex repressed HIV-1 transcription
whereas the PBAF subclass promoted transcription. Our observa-
tion (Figure 5A) that a BRG-1 site upstream of the provirus is
Proviral Integration, Abundance and Expression
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associated with silencing of Tax, while a BRG-1 site downstream is
associated with Tax expression, is consistent with our conclusion
(above) that transcriptional interference dominates the transcrip-
tional interaction between the provirus and the flanking host
genome.
The Ini1 subunit of SWI/SNF interacts directly with HIV-1
integrase [37]; a fraction of Ini1 moves transiently to the cytoplasm
to associate with the HIV-1 preintegration complex [38].
However, the function of Ini1 in HIV-1 proviral integration and
expression in vivo is not understood. We found that genomic sites
for Ini1 binding were significantly associated with HTLV-1
proviral integration (Figure 2B). The presence of an Ini1 site
1 kb downstream of the provirus was associated with spontaneous
Tax expression, similar to the effect of the downstream BRG-1
site. Finally, the SWI/SNF subunit BAF155 was overrepresented
1 kb upstream of the integration site (Figure 2B), and was
associated with Tax silencing when present either upstream or
downstream of the provirus (Figure 5B).
The HTLV-1 Tax protein acts in concert with host cell
transcription factors (notably CBP/p300) on the promoter/
enhancer in the viral 59 LTR, driving plus-strand transcription
in a strong positive feedback loop. Tax also acts on response
elements for NF-kB, CREB and the serum response factor (SRE)
to upregulate expression of a wide range of host genes [39].
Finally, Tax promotes cell cycle progression by accelerating
passage through G1 and inhibiting the G1/S and G2/M
checkpoints [40]. The net effect of Tax expression is therefore to
drive activation and proliferation of the infected T cell. We
previously reported that spontaneous Tax expression in fresh
unstimulated PBMCs was associated with proliferation of the
respective cell in vivo [41]. We therefore expected to observe a
positive correlation between the frequency of spontaneous Tax
expression by a given clone ex vivo and the abundance of that
clone in vivo. However, the results obtained here (Figure 6)
demonstrate the opposite, i.e. a highly significant negative
correlation. This correlation is likely to be caused by the strong
host immune response to the virus. The Tax protein is highly
immunodominant in the class 1 MHC-restricted cytotoxic T
lymphocyte (CTL) response to HTLV-1 [14,42], and the tax gene
is frequently silenced in vivo by mutation or epigenetic changes
such as DNA methylation in both untransformed and malignantly
transformed (leukemic) cells [43]. Cells that express a high level of
Tax are killed by CTLs faster than low Tax-expressing cells [44].
Therefore, suppression or loss of Tax expression may confer a
survival advantage on the infected clone in vivo. We conclude that
the small (low-abundance) HTLV-1-infected clones express Tax at
a higher rate and turn over faster in vivo than the high-abundance
clones. It is possible that the critical role of Tax in the HTLV-1
lifecycle is not to maintain clone abundance but rather to promote
virion production and infection of new cells by cell contact via the
virological synapse [45,46].
The negative correlation observed between clone abundance
and the percentage of Tax+ cells, although it was highly significant
in all patients combined, was not uniform in every patient. In a
small number of patients (in particular those with a high
oligoclonality index, Supplementary Figure S8), the most abun-
dant clones (bin 4, clones with greater than 10 cells) contained a
high proportion of Tax+ cells, suggesting that certain antigen-
expressing clones escaped control by the immune response, for
example by CTL escape mutations in the tax gene [47]. However,
clone-specific sequencing of exon 3 of the tax gene of 38 clones
(.10 cells) from 8 patients did not reveal significant differences in
the occurrence of Tax mutations between clones with a high or
low frequency of Tax+ cells; and only in one patient was a
difference in amino acid sequence found between one clone and
the others (data not shown).
Interestingly, while Tax+ cells were more frequent in low-
abundance clones, certain features favouring proviral expression
(e.g. a downstream host TSS) also favoured clonal expansion. The
association between clonal abundance and proviral integration
within 1 kb of a downstream host TSS was maintained even
within Tax2 clones, consistent with the idea that the selective
expansion of these clones is driven by other proviral genes.
These observations raise the possibility that the equilibrium
abundance of an HTLV-1-infected T cell clone in vivo is
determined not by Tax but by the HBZ gene, encoded on the
negative strand of the provirus. Satou et al showed that HBZ
mRNA promoted proliferation of the infected cell, and whereas
Tax expression is frequently undetectable, HBZ appears to be
persistently expressed in fresh cells isolated from both non-
malignant cases of HTLV-1 infection and cases of adult T-cell
leukemia/lymphoma [16]. Further, Macnamara et al recently
showed that the CTL response to HBZ is a critical determinant of
the equilibrium proviral load in vivo [17]
In this study we examined Tax expression only among CD4+ T
cells. A small percentage of infected cells are CD8+ T cells [48,49];
it is possible that the genomic factors that determine targeting and
expression of HTLV-1 differ in CD8+ cells. Also, the propensity of
a cell to express Tax was measured by quantifying the frequency of
spontaneous Tax expression after 18 hours incubation in vitro.
Two lines of evidence suggest that this measure is relevant to
HTLV-1 infection and pathogenesis in vivo. First, cells which
express Tax ex vivo turn over faster in vivo [41]. Second, the
proportion of CD4+ cells that express Tax after overnight culture
is significantly associated with the HTLV-1 inflammatory disease
HAM/TSP [50]. The individuals studied here were all patients
with HAM/TSP: the mean level of spontaneous Tax expression is
lower in asymptomatic HTLV-1 carriers, but it is unlikely that the
molecular mechanisms that govern proviral latency differ quali-
tatively between asymptomatic carriers and patients with HAM/
TSP.
It will be important to compare the present results with the
genomic factors associated with HBZ expression or silencing. At
Figure 6. Tax+ cells are more frequent in smaller clones. Mean
fraction of Tax+ cells in bins of increasing clonal abundance (total
number of cells in each respective clone). The fraction of Tax+ cells was
negatively correlated with clonal abundance (p,10216, x2 test for
trend).
doi:10.1371/journal.ppat.1003271.g006
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present this cannot be done by flow-sorting because existing HBZ-
specific antibodies are insufficiently sensitive to detect the low
expression levels of HBZ protein in primary cells. We are currently
testing the hypothesis that Tax-specific and HBZ-specific CTL
clones selectively lyse different clonal populations in vitro.
We have identified host genomic factors that determine the
integration site, the proviral expression and selective clonal
expansion of HTLV-1 in natural infection in vivo: these factors




Blood samples were donated by HTLV-1-infected individuals
attending the HTLV-1 clinic at the National Centre for Human
Retrovirology (Imperial College Healthcare NHS trust) at St
Mary’s Hospital, London UK, with fully informed written consent.
This study was approved by the UK National Research Ethics
Service (NRES reference 09/H0606/106).
DNA samples (Table 1)
PBMCs were isolated using Histopaque-1077 (Sigma-Aldrich)
and cryopreserved in FBS (Gibco) containing 10% DMSO
(Sigma-Aldrich). DNA extraction was carried out using the
DNeasy Blood & Tissue kit (Qiagen) according to the manufac-
turer’s protocol.
In vitro infection
In vitro infection was carried out in two independent assays as
previously described [11]. Jurkat (JKT) cells were co-cultured for
3 h with c-irradiated (137Cs, 40,000 cGy) MT2 cells [51], labelled
with anti-CD4 MicroBeads (Miltenyi). MT2 cells were then
depleted from the co-culture using magnetic separation (Miltenyi),
and infected JKT cells were maintained in culture for 14 days in
RPMI (supplemented by L-glutamine, penicillin, streptomycin)
containing 10% FBS for 18 hours at 37C with 5% CO2. Genomic
Figure 7. Genomic correlates of HTLV-1 proviral targeting, clonal expansion and proviral expression. (A) Factors associated with the
presence or absence of spontaneous Tax expression by a given cell after short-term (18 h) in vitro incubation. (B) Features of the genomic
environment of the provirus associated either with initial integration (left panel), or clonal expansion in vivo (right panel). Findings were made in the
present study unless otherwise stated. TSS – transcription start site. TFBS – transcription factor binding site.
doi:10.1371/journal.ppat.1003271.g007




in vitro (1) 4521 N/A [11]
in vitro (2) 1805 N/A This publication
In vivo (1) 785631 63 [11]
In vivo (2) 20202 10 This publication
Tax Negative 6700 10 (pooled) This publication
Tax Positive 13054 10 (pooled) This publication
Random UIS 176505 N/A This publication
1For the purpose of this work, only one time point was used for each patient
(most recent available if multiple time points were originally analysed).
doi:10.1371/journal.ppat.1003271.t001
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DNA was extracted and the proviral integration sites (IS) analysed
as previously described [11]. IS from MT2 were also analysed to
exclude possible contamination of the JKT IS. No contaminating
MT2 IS were found after 14 days.
Tax sorting
See also supplementary Figure S5, supplementary Table S6.
PBMCs from 10 patients with HAM/TSP with a high proviral
load (range 12.2–50.6 copies per 100 PBMC) were depleted of
CD8+ cells using magnetic depletion (Miltenyi) and incubated in
RPMI (supplemented by L-glutamine, penicillin, streptomycin)
containing 10% FBS for 18 hours at 37C with 5% CO2. After
18 h culture, the cells were stained for intracellular expression of
Tax (anti-Tax mAb LT4) and sorted using FACS (FACSAria IIIU,
BD Biosciences) to isolate two populations of live CD4+ cells based
on Tax expression. Gates were set (FACSDiva, BD Biosciences) to
ensure a clear demarcation between the Tax+ and Tax2
populations (Figure S6). DNA was extracted from whole unsorted
PBMCs from each patient and analysed separately to identify the
patient of origin of each clone; 46% of the clones were attributed
in this way. To calculate the fraction of Tax+ cells in a given clone,
the frequency of Tax+ and Tax2 cells were normalized to the mass
of genomic DNA per cell from each respective cell population, to
correct for experimental variation in efficiency of genomic DNA
isolation (Table S6),
Analysis of IS
Identification and quantification of proviral integration sites was
done as previously described [11]. HTLV-1 infected DNA was
randomly sheared by sonication (Covaris S2) and then blunt-
ended (Klenow polymerase) and ligated to a partly double-
stranded DNA linker. Following a nested PCR step, the resulting
DNA libraries were deep sequenced using the Illumina GA-II
platform. DNA sequence was aligned to the human genome
reference (UCSC hg18, excluding haplotype and ‘‘random’’
sequences) using the ELAND algorithm. Distinct IS were grouped
based on integration site and quantified based on number of
distinct shear sites isolated and the respective patient’s proviral
load.
DNA sequences from ,190000 random sites in the human
genome (hg18) were generated using Galaxy [52,53,54] and back-
aligned to the human genome using the same pipeline to eliminate
any potential bias due to alignment limitations.
Calculation of clonal abundance
The absolute abundance of a given clone was defined as the
number of proviral copies of that clone per 104 PBMCs. Given ni -
the number of proviral copies for the ith clone, and S – the total
number of clones identified in the sample, the absolute abundance







Clone abundance bins were defined on a logarithmic scale since
proviral load (used in calculation of abundance) follows a
logarithmic distribution [55]. The number of clones in each clone
abundance bin is given in Table S1. For samples sorted for Tax
protein expression, where proviral load data were not available,
the clonal abundance bins were set according to proviral copy
count.
Bioinformatic analysis of genomic environment
Transcription units and CpG island data were retrieved from
the NCBI (ftp.ncbi.nih.gov/gene/) and UCSC tables [56],
respectively. Annotations to the human genome were obtained
from published datasets (Table S3) including ChIP-seq experi-
ments on primary CD4+ T cells where available; otherwise, data
on human CD4+ T cell lines or other human cell lines were used.
We used the SISSRs algorithm [57] to identify the position of a
putative transcription factor binding site in published ChIP-seq
data where raw ChIP-seq data were available.
Annotations positions were compared to the IS using the R
package hiAnnotator (http://malnirav.github.com/hiAnnotator),
kindly provided by N. Malani and F. Bushman (University of
Pennsylvania, USA).
Statistical analysis
Statistical analysis was carried out using R version 2.13.0
(http://www.R-project.org/). Two separate logistic regression
analyses were carried out, respectively, to identify independent
predictors of HTLV-1 integration targeting and independent
predictors of Tax positivity. Genomic annotations used to derive
input variable were published ChIP-seq datasets (see Bioinformatic
analysis above; Table S3). For integration targeting, the binary
outcome measure was a ‘‘true’’ integration site (from 4521
identified in vitro integration sites) or a ‘‘false’’ integration site
(45210 random genomic locations). For spontaneous Tax
expression, the binary outcome was Tax positivity (20813 Tax+
cells) or Tax negativity (10326 Tax2 cells). Each TFBS was tested
(presence or absence of the TFBS within a given distance of the
integration site) as an independent predictor in each analysis. For
each outcome variable, two separate analyses were carried out,
respectively at two distances of the integration site - 100 bases and
1 kb.
First, for each TFBS and at each distance, we tested whether the
relative position (upstream/downstream) of the integration site
and the TFBS determined the outcome by using a likelihood ratio
test to compare two competing models: 1) presence or absence of
TFBS upstream or (separately) downstream; 2) presence or
absence of TFBS, regardless of relative position. Next, we carried
out univariate analysis of each individual TFBS, based on the
model chosen by the likelihood ratio test. Only TFBS that were
significant (p-value,0.05) after correction for multiple compari-
sons (Benjamini-Hochberg) were used in the multivariate analysis.
Multivariate analysis was carried out using a step-down logistic
regression method.
Supporting Information
Figure S1 Influence of host TFBS on integration site
targeting – in vitro. Bias in integration in proximity to TFBS
(based on ChIP-seq experiments), measured by the odds ratio
compared to random expectation. The bias was maintained across
separate datasets, generated by independent in vitro experiments.
Dotted line denotes random expectation (OR=1).
(TIF)
Figure S2 Influence of host TFBS on integration site
targeting – in vivo. Bias in integration in proximity to TFBS
(based on ChIP-seq experiments), measured by the odds ratio
compared to random expectation. The pattern of bias was
maintained between different patient clinical groups. Dotted line
denotes random expectation (OR=1). ATLL=Adult T-cell
leukaemia/lymphoma . HAM/TSP=HTLV-1 associated mye-
lopathy/Tropical spastic paraparesis. AC=Asymptomatic carrier.
(TIF)
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Figure S3 Influence of host TFBS on clonal abundance
in vivo. Bias in frequency of integration in proximity to TFBS
(based on ChIP-seq experiments), measured by the odds ratio
compared to random expectation. TFBS that were associated with
integration targeting showed a stronger bias (higher OR) in the
clones least expanded in vivo. Clonal abundance is expressed as
the number of cells in given clone per 104 PBMCs. Dotted line
denotes random expectation (OR=1).
(TIF)
Figure S4 The genomic environment at the HTLV-1
proviral integration site determines integration target-
ing in vitro and clonal abundance in vivo. Frequency of
integration in proximity to CpG islands in clones for in vitro (in
blue) and in vivo (purple) integration.
(TIF)
Figure S5 Protocol for flow-sorting of Tax-expressing
cells. (A) CD8+ cell-depleted PBMCs were studied from 10
patients with HAM/TSP with a high proviral load. The cells were
incubated overnight, fixed and stained for Tax and surface CD4
expression, and sorted on a high-speed flow cytometer (see Figure
S6 for details). (B) Recovered cells from all 10 patients were
combined in two pools, respectively CD4+Tax+ cells and
CD4+Tax2 cells. (C) Genomic DNA was extracted from each
pool of cells and integration site analysis carried out as described.
(TIF)
Figure S6 Flow cytometry sorting by Tax expression. (A)
Representative FACS plots of the gating procedure used (from 1 of
10 samples studied). Lower middle panel shows gating of
CD4+Tax+ (‘Tax pos’) and CD4+Tax2 (‘Tax neg’) populations;
these gates were set to distinguish unequivocally between Tax+ and
Tax2 populations. (B) Purity testing of Tax2 sorted cells: Tax+
cells not detected. C) Purity testing of Tax+ sorted cells: 0.2% were
Tax2.
(TIF)
Figure S7 Majority of HTLV-1-infected clones were
either 100% Tax+ or 0% Tax+. Frequency distribution of
clones according to the frequency of Tax+ cells in each respective
clone, binned according to number of sister cells detected in
sample: bin 1: 1 cell detected; bin 2: 2 or 3 cells detected; bin 3: 4
to 10 cells detected; bin 4: over 10 cells detected.
(TIF)
Figure S8 Tax+ cells were more frequent in smaller
clones. Mean fraction of Tax+ cells within each bin, in bins of
increasing clonal abundance (total number of cells in each
respective clone). In the majority of patients there was an inverse
correlation between clone abundance bin and fraction of Tax+
cells: this correlation was highly significant in all patients
combined (P,10232). However in certain patients (particularly
those with a high oligoclonality Index) the most abundant clones
contained a high proportion of Tax+ cells. Clone abundance bins
were defined as in Figure S7.
(TIF)
Table S1 In vivo integration sites – sample data by
clone abundance.
(DOC)
Table S2 In vivo integration sites – sample data by
patient code.
(DOC)
Table S3 List of annotations datasets used.
(DOC)
Table S4 Odds ratio and clone counts data for a
selection of TFBS – in vitro, in vivo vs. random sites.
(XLS)
Table S5 Odds ratio and clone counts data for a
selection of TFBS – clonal abundance bins vs. random
sites.
(XLS)
Table S6 Tax sorting experiment – sample data.
(DOC)
Table S7 Multivariate analysis results – detailed odds
ratios and confidence intervals.
(XLS)
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